Astex – Oncology and CNS Drug Discovery & Development

Committed to the fight against cancer and CNS disorders

Committed to the fight against cancer and CNS disorders

World leading innovative drug discovery & development

Our research and development teams utilize our cutting edge technology platform in the relentless pursuit of innovative solutions that address the extensive and complex challenges in oncology and diseases of the CNS.

Astex has built a rich product portfolio with multiple drugs in clinical development

Latest from Astex

19 September 2023

Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia

8 August 2023

Astex Expands Drug Discovery Collaboration With MSD

In the News

18 May 2023
Astex wins Life Science Company of the Year at the Cambridge Independent Science and Technology Awards 2023

15 December 2022
Astex and AstraZeneca deliver ‘landmark’ breast cancer drug

22 November 2022
Cancer Research UK and Newcastle University announce alliance extension with Astex Pharmaceuticals (UK)

Sustaining Innovation

Sustaining Innovation Postdoctoral Training Program

Career Opportunities

We seek to attract and retain talented individuals who are passionate about improving patient outcomes.

icon_Interactive_White

Interactive Scientific Resources

Explore 3D protein-ligand structures from recent Astex publications.

Download software developed by Astex scientists.